Therapeutic Pipeline Program – Fall 2013- Michael J. Fox Foundation

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON’S RESEARCH (MJFF) SEEKS TO FUND BOTH PRECLINICAL AND CLINICAL DEVELOPMENT OF THERAPEUTICS THAT MAY ALTER THE COURSE OF PD PROGRESSION

Objecte

The goal of the Therapeutic Pipeline Program is to support therapeutic development around targets within pathways that have been implicated in altering the course of Parkinson’s disease (disease modifying strategies). The pathways selected are of interest to PD given their presumed role in the pathophysiology of disease progression involving environmental toxins, protein handling, inflammatory mediators and genes associated with select populations of carriers.

Although most traditional therapies involve pharmacological approaches, MJFF is also open to alternative strategies, including gene therapy, biological, surgical and non-invasive/non-pharmaceutical approaches that can have significant impact for patients. Moreover, as drug targets may be shared among multiple diseases and/or drugs may hit multiple disease targets, MJFF is also interested in drug repositioning of molecules for PD that have been approved or shown to be clinically safe for other indications.

Termini IISPV

Cal comunicar abans del 5 de març de 2013 que es vol participar a la convocatòria, enviant un e-mail a convocatories@iispv.cat . Termini: 21 de març de 2013

Termini Oficial

Informational Conference Call*: March 7, 2013, 12:00 p.m. EST
Pre-proposals Due: April 3, 2013, 6:00 p.m. EST
Full Application Invites Sent to Applicants: April 24, 2013
Full Applications Due: June 12, 2013
Anticipated Award Announcement: September 2013
Anticipated Funding: October 2013

Estàs interessat?

Omple el següent formulari per rebre més informació: